As of 3:59pm ET
| +1.95 / +5.13%|
The 6 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 80.00, with a high estimate of 89.00 and a low estimate of 17.00. The median estimate represents a +100.25% increase from the last price of 39.95.
The current consensus among 7 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.